Shyam Patel, DO
Hospitalist · San Diego, CANPI 1700184157
Payments from drug & device makers
Across 53 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$315
- Novartis$216
- Eyevance Pharmaceuticals LLC$153
- Ultragenyx Pharmaceutical Inc.$49
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$48
- La Jolla Pharmaceutical Company$34
- plus $148 from 8 others
What the payments were for
- Food & beverage$964100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 19 | $315 |
| Novartis | 10 | $216 |
| Eyevance Pharmaceuticals LLC | 8 | $153 |
| Ultragenyx Pharmaceutical Inc. | 2 | $49 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $48 |
| La Jolla Pharmaceutical Company | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Pfizer | 2 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| AbbVie | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| AstraZeneca | 1 | $12 |
How this compares
$964 in reported general payments places this provider in the 90th percentile of 2,469 hospitalist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $126 |
| Metoprolol Succinate | 12 | $105 |
| Doxycycline Hyclate | 26 | $104 |
| Prednisone | 39 | $104 |
| Levofloxacin | 19 | $102 |
| Atorvastatin Calcium | 21 | $73 |
| Amlodipine Besylate | 11 | $30 |
| Furosemide | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in San Diego
- Omar AldaasSan Diego$24K
- Danielle BrazelSan Diego$8K
- Kinaan JavedSan Diego$5K
- Gregory SeymannSan Diego$5K
- Christina BohrSan Diego$5K
- John BeckesNational City$15.5M
- Samuel PenzinerLos Angeles$2.5M
- Michael Abdel-MalekDublin$2M
- Billy HourMission Hills$1.9M
- Jennifer SchneiderSanta Rosa$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.